Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income	$ (58,750)	$ 83,210
Depreciation and amortization	178,338	66,564
Amortization of Inventory Step-up	22,676	0
Noncash lease expense	17,382	7,165
Provision for doubtful accounts	214	342
Provision for warranty and returns	3,439	752
Stock compensation	28,597	19,236
Loss on disposal of property and equipment	2,391	1,083
Bond premium amortization	254	514
Debt Issuance Costs amortization	5,254	216
Change in fair value of contingent earn-out	(31,253)	0
Inventory Recall Expense	0	3,380
Sparepartsusage	7,915	9,831
Other Noncash Income (Expense)	(2,855)	2,908
Accounts receivable	(8,956)	3,807
Inventories	(151,840)	16,510
Prepaid expenses and other assets	20,074	3,557
Increase (Decrease) in Other Operating Assets	(22,594)	(13,593)
Accounts payable	30,413	(10,374)
Accrued liabilities	(38,070)	(8,317)
Income taxes, including excess tax benefits and deferred income taxes	(63,047)	(1,874)
Net cash provided by operating activities	(60,418)	184,917
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(68,715)	(46,464)
Proceeds from sale of asset	933	218
Intangible assets additions	(6,560)	(10,216)
Payments to Acquire Equity Method Investments	0	(3,250)
Purchases of investment securities	(3,397)	(10,034)
Proceeds from sale of investment securities	36,433	12,000
Net cash used in investing activities	(1,885,470)	(57,746)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	1,672,631	0
Repayments of Long-term Debt	20,250	0
Payments of Debt Issuance Costs	(1,852)	0
Proceeds from exercise of stock options	7,906	6,966
Finance Lease, Principal Payments	(477)	(448)
Payment, Tax Withholding, Share-based Payment Arrangement	10,541	8,109
Net cash (used in) provided by financing activities	1,647,417	(1,591)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(10,477)	(2,192)
Effect of Exchange Rate on Cash [Abstract]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(308,948)	123,388
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	243,879	519,485
Supplemental Cash Flow Information [Abstract]
Capital Expenditures Incurred but Not yet Paid	2,757	2,897
NON-CASH INVESTING ACTIVITIES
Fair Value of Assets Acquired	1,658,937
Payments to Acquire Businesses, Net of Cash Acquired	(1,844,164)	0
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	(575,975)
Contingent consideration all Acquisitions	(55,158)
Goodwill, acquired during period	1,442,849
Liabilities Assumed	(626,489)
Foreign Infusion System Supplier
NON-CASH INVESTING ACTIVITIES
Liabilities Assumed	$ 0	$ (3,100)